ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 110 filers reported holding ERASCA INC in Q3 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,893 | -35.1% | 36,494 | -9.0% | 0.04% | -33.3% |
| Q2 2023 | $110,745 | +76.0% | 40,125 | +92.0% | 0.07% | +88.6% |
| Q1 2023 | $62,915 | -49.6% | 20,902 | -27.8% | 0.04% | -46.2% |
| Q4 2022 | $124,731 | -25.8% | 28,940 | +34.7% | 0.06% | -3.0% |
| Q3 2022 | $168,000 | +41.2% | 21,487 | +0.7% | 0.07% | +52.3% |
| Q2 2022 | $119,000 | +20.2% | 21,337 | +85.0% | 0.04% | 0.0% |
| Q1 2022 | $99,000 | -47.9% | 11,532 | -5.6% | 0.04% | -38.9% |
| Q4 2021 | $190,000 | – | 12,213 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |